MRSA biofilm inhibition
Abstract:
Provided is a darwinolide compound having a previously undescribed carbon skeleton and the crystalline form thereof. Also provided are processes of isolating darwinolide, compositions comprising darwinolide, and methods of treating infection, such as a methicillin-resistant Staphylococcus aureus biofilm infection.
Public/Granted literature
Information query
Patent Agency Ranking
0/0